Reversible visual disturbance due to cryptococcal uveitis in a non-HIV individual

Medical Mycology

Volumn 46, Issue 4, 2008, Pages 367-370

  Nakamura, Shigeki ^a   Izumikawa, Koichi ^a   Seki, Masafumi ^a   Fujimoto, Kyoko ^b   Mishima, Kazuaki ^b   Kakeya, Hiroshi ^a   Yamamoto, Yoshihiro ^a   Yanagihara, Katsunori ^a   Mizuta, Yohei ^a   Kitaoka, Takashi ^b   Kohno, Shigeru ^b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cryptococcal uveitis; Disseminated cryptococcosis; Fluconazole loading dose; Non HIV individual; V A shunt

Indexed keywords

AMPHOTERICIN B; C REACTIVE PROTEIN; CORTICOSTEROID; DEXAMETHASONE; FLUCONAZOLE; FLUCYTOSINE; FUNGUS ANTIGEN; ITRACONAZOLE;

ADULT; AMNESIA; ANTERIOR EYE CHAMBER; ANTIBIOTIC SENSITIVITY; AQUEOUS HUMOR; ARTICLE; BLOOD VESSEL SHUNT; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENDOPHTHALMITIS; ERYTHROCYTE SEDIMENTATION RATE; FUNGUS ISOLATION; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; INTRAOCULAR HEMORRHAGE; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUROSURGERY; PROSTATE FLUID; TREATMENT DURATION; TUBERCULIN TEST; UVEITIS; VISUAL ACUITY;

ANTIFUNGAL AGENTS; CEREBROSPINAL FLUID SHUNTS; CRYPTOCOCCOSIS; ENDOPHTHALMITIS; FLUCONAZOLE; HIV SERONEGATIVITY; HUMANS; HYDROCEPHALUS; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; VISION DISORDERS;

CRYPTOCOCCUS NEOFORMANS VAR. GRUBII;

EID: 42349097843     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780701885461     Document Type: Article

References (19)

1. Grosse, P., Schulz, J. and Schmierer, K. (2003) Diagnostic pitfalls in eosinophilic cryptococcal meningoencephalitis. Lancet Neurol, 8, p. 512.
2. National Committee for Clinical Laboratory Standards (NCCLS)
3. Rex, JH, Pfaller, MA and Galgiani, JN (1997) Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis, 24, pp. 235-247.
4. Denning, DW, Armstrong, RW, Eishman, M. and Stevens, DA. (1991) Endophthalmitis in a patient with disseminated cryptococcosis and AIDS who was treated with itraconazole. Rev Infect Dis, 13, pp. 1126-1130.
5. Crump, JR, Elner, SG, Elner, VM and Kauffman, CA. (1992) Cryptococcal endophthalmitis: Case report and review. Clin Infect Dis, 14, pp. 1069-1073.
6. Park, MK, Hospenthal, DR and Bennett, JE. (1999) Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. Clin Infect Dis, 28, pp. 629-633.
7. Tang, LM. (1990) Ventriculoperitoneal shunt in cryptococcal meningitis with hydrocephalus. Surg Neurol, 33, pp. 314-319.
8. Magham, D., Gerding, DN, Peterson, LR and Sarori, GA. (1983) Fungal meningitis presenting as hydrocephalus. Arch Intern Med, 143, pp. 728-731.
9. Walsh, TJ, Schlegel, R., Moody, MM, Costerton, JW and Salcman, M. (1986) Ventriculoatrial shunt infection due to Cryptococcus neoformans: An ultrastructual and quantitative microbiological study. Neurosurgery, 18, pp. 373-375.
10. Crum, CP and Feldman, PS. (1981) Cryptococcal peritonitis complicating a ventriculoperitoneal shunt in unsuspected cryptococcal meningitis. Human Path, 12, pp. 660-663.
11. Yadav, SS, Perfect, J. and Friedman, AH. (1988) Successful treatment of cryptococcal ventricular shunt infection with systemic therapy alone. Neurosurgery, 23, pp. 372-373.
12. Ingram, CW, Haywood 3rd, HB, Morris, VM, Allen, RL and Perfect, JR. (1993) Cryptococcal ventricular-peritoneal shunt infection: Clinical and epidemiological evaluation of two closely associated cases. Infect Control Hosp Epidemiol, 14, pp. 719-722.
13. Hossain, MA, Mukherjee, PK, Reyes, G., Long, L. and Ghannoum, MA. (2002) Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model. J Chemother, 14, pp. 351-360.
14. Mayanja-Kizza, H., Oishi, K. and Mitarashi, S. (1998) Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis, 26, pp. 1362-1366.
15. Yadav, SS, Perfect, J. and Friedman, AH. (1988) Successful treatment of cryptococcal ventricular shunt infection with systemic therapy alone. Neurosurgery, 23, pp. 372-373.
16. Martinez, LR and Casadevall, A. (2006) Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother, 50, pp. 1021-1033.
17. Mian, UK, Mayers, M. and Garg, Y. (1998) Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady state. J Ocul Pharmacol Ther, 14, pp. 459-471.
18. Abbasoglu, OE, Hosal, BM, Sener, B., Erdemoglu, N. and Gursel, E. (2001) Penetration of topical fluconazole into human aqueous humor. Exp Eye Res, 72, pp. 147-151.
19. Kwon-Chung, KJ, Polacheck, I. and Bennett, JE. (1992) Cryptococcosis. Medical Mycology, pp. 397-446. Lea & Febiger, Philadelphia